MetaCap

Abivax SA ADR Company Profile

NASDAQ: ABVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

73.20-7.45 (-9.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Abivax SA at a glance

Abivax SA ADR (NASDAQ: ABVX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Paris, France. Abivax SA is led by Mr. Marc M. P. de Garidel M.B.A. and employs about 98 people. The company's shares have traded publicly since 2023.

At a market capitalization of $6.41 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001956827, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Abivax SA do?

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Business description based on the company's public filings.

Company information

Legal name
Abivax SA ADR
Ticker
NASDAQ: ABVX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Marc M. P. de Garidel M.B.A.
Employees
98
Headquarters
7-11 Boulevard Haussmann, Paris, France
Phone
33 1 53 83 09 63
Website
abivax.com
IPO year
2023
SEC CIK
0001956827

Companies similar to Abivax SA

ABVX peer companies
CompanyPrice% ChgMarket capCompare
MIRMMirum Pharmaceuticals Inc.96.13+0.65%$6.28Bvs ABVX
AXSMAxsome Therapeutics Inc.129.36-4.66%$6.80Bvs ABVX
SUPNSupernus Inc.28.61+0.92%$5.94Bvs ABVX
CORTCorcept Therapeutics Incorporated63.62-2.09%$6.96Bvs ABVX
ARWRArrowhead Pharmaceuticals Inc.41.37-5.22%$5.85Bvs ABVX
CYTKCytokinetics Incorporated50.78-1.32%$7.07Bvs ABVX
LGNDLigand Pharmaceuticals Incorporated286.85-0.03%$5.74Bvs ABVX
GRFSGrifols S.A. ADR8.15-0.61%$5.55Bvs ABVX

Related